Venetoclax combined with daunorubicin and cytarabine (2+6) in acute myeloid leukemia: Updated results of a phase II trial

被引：0

作者：

Suo, Xiaohui ^{[1
]}

Fang, Zheng ^{[2
]}

Wang, Dongmei ^{[3
]}

Zhao, Liyun ^{[4
]}

Liu, Jie ^{[5
]}

Li, Hong ^{[6
]}

Ma, Xiaojun ^{[1
]}

Zhang, Congcong ^{[1
]}

Zhao, Xuemei ^{[2
]}

Shi, Rui ^{[3
]}

Wu, Yan ^{[3
]}

Jiao, Zongjiu ^{[4
]}

Song, Jiaojie ^{[4
]}

Zhang, Ling ^{[5
]}

Li, Ling ^{[7
]}

Zhang, Suping ^{[8
]}

Lu, Xinxiao ^{[9
]}

Yuan, Linyu ^{[9
]}

Gao, Sifeng ^{[10
]}

Zhang, Jilei ^{[10
]}

Liu, Kaiqi ^{[11
]}

Zhao, Xingli ^{[9
]}

Bai, Guanchen ^{[10
]}

Mi, Yingchang ^{[11
]}

机构：

[1] Handan Cent Hosp, Dept Hematol, Handan, Hebei, Peoples R China

[2] Second Peoples Hosp Guiyang, Dept Hematol, Guiyang, Guizhou, Peoples R China

[3] Harrison Int Peace Hosp, Dept Hematol, Hengshui, Hebei, Peoples R China

[4] People Hosp XingTai, Dept Hematol, Xing Tai, Hebei, Peoples R China

[5] Sinopharm Tongmei Gen Hosp, Dept Hematol, Datong, Shanxi, Peoples R China

[6] Daqing Oilfied Gen Hosp, Dept Hematol, Daqing, Heilongjiang, Peoples R China

[7] Inner Mongolia Peoples Hosp, Dept Hematol, Hohhot, Neimenggu, Peoples R China

[8] Zhengzhou Univ, Dept Hematol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China

[9] Tianjin Peoples Hosp, Oncol Ctr, Dept Hematol, Tianjin, Peoples R China

[10] Qingdao Univ, Dept Hematol, Affiliated Taian City Cent Hosp, Tai An, Shandong, Peoples R China

[11] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China

来源：

HEMATOLOGICAL ONCOLOGY | 2024年 / 42卷 / 04期

基金：

中国国家自然科学基金;

关键词：

SINGLE-ARM; CHEMOTHERAPY;

D O I：

10.1002/hon.3296

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 5 条

[1] Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy
Chua, Chong Chyn
Roberts, Andrew W.
Reynolds, John
Fong, Chun Yew
Ting, Stephen B.
Salmon, Jessica M.
MacRaild, Sarah
Ivey, Adam
Tiong, Ing Soo
Fleming, Shaun
Brown, Fiona C.
Loo, Sun
Majewski, Ian J.
Bohlander, Stefan K.
Wei, Andrew H.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (30) : 3506 - +
[2] Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
DiNardo, Courtney D.
Lachowiez, Curtis A.
Takahashi, Koichi
Loghavi, Sanam
Kadia, Tapan
Daver, Naval
Xiao, Lianchun
Adeoti, Maria
Short, Nicholas J.
Sasaki, Koji
Wang, Sa A.
Borthakur, Gautam
Issa, Ghayas
Maiti, Abhishek
Alvarado, Yesid
Pemmaraju, Naveen
Bravo, Guillermo Montalban
Masarova, Lucia
Yilmaz, Musa
Jain, Nitin
Andreeff, Michael
Garcia-Manero, Guillermo
Kornblau, Steven
Ravandi, Farhad
Jabbour, Elias
Konopleva, Marina Y.
Kantarjian, Hagop M.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : 1035 - 1043
[3] Kadia TM, 2021, LANCET HAEMATOL, V8, pE552, DOI 10.1016/S2352-3026(21)00192-7
[4] Venetoclax combined with daunorubicin and cytarabine (2+6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
Suo, Xiaohui
Zheng, Fang
Wang, Dongmei
Zhao, Liyun
Liu, Jie
Li, Ling
Zhang, Zhihua
Zhang, Congcong
Li, Yinling
Yang, Sisi
Zhao, Xuemei
Shi, Rui
Wu, Yan
Jiao, Zongjiu
Song, Jiaojie
Zhang, Ling
Lu, Xinxiao
Yuan, Linyu
Gao, Sifeng
Zhang, Jilei
Zhao, Xingli
Bai, Guanchen
Liu, Kaiqi
Mi, Yingchang
[J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[5] Venetoclax plus 3+7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
Wang, Huafeng
Mao, Liping
Yang, Min
Qian, Pengxu
Lu, Huan
Tong, Hongyan
Xie, Wanzhuo
Zhou, De
Huang, Xin
Wang, Yungui
Xu, Gaixiang
Lu, Ying
Wei, Juying
Mai, Wenyuan
Ye, Xiujin
Meng, Haitao
Shen, Yaojia
Huang, Jian
Yu, Wenjuan
Sun, Jie
Sheng, Jianpeng
Yan, Xiaoyan
Jin, Jie
Zhu, Hong-Hu
[J]. LANCET HAEMATOLOGY, 2022, 9 (06): : E415 - E424

← 1 →